Clinical features and survival of treatment with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease.

被引：0
|
作者：
Mendoza, M. A. P. [1 ]
Contreras, A. [1 ]
Lafuente, G. [1 ]
Luque Buzo, E. [1 ]
De la Casa Fages, B. [1 ]
Gonzalez, M. [1 ]
Perez Sanchez, J. [2 ]
Grandas Perez, F. [1 ]
机构：
[1] Dept Neurol, Madrid, Spain
[2] Movement Disorders Unit, Madrid, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-636
引用
收藏
页码：836 / 836
页数：1
相关论文
共 50 条
  • [41] Safety of levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease patients receiving=2000 mg daily dose of levodopa
    Zadikoff, C.
    Boyd, J.
    Dubow, S.
    Bergmann, L.
    Robieson, W.
    Ijacu, H.
    Benesh, J.
    MOVEMENT DISORDERS, 2017, 32
  • [42] HUNGARIAN EXPERIENCES WITH LEVODOPA/CARBIDOPA INTESTINAL GEL IN THE TREATMENT OF ADVANCED PARKINSON'S DISEASE
    Nagy, Helga
    Takats, Annannaria
    Toth, Adrian
    Bereczki, Daniel
    Klivenyi, Peter
    Dezsi, Livia
    Dibo, Gyoergy
    Vecsei, Laszlo
    Kovacs, Norbert
    Aschermann, Zsuzsa
    Komoly, Samue, I
    Varannai, Lajos
    Zemlenyi, Gyoengyi
    Valikovics, Attila
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (11-12): : 385 - 389
  • [43] Clinical characteristics associated with early discontinuation of Levodopa-Carbidopa Intestinal Gel infusion in patients with advanced Parkinson Disease
    Rivero-Rodriguez, D.
    Morales-Casado, M.
    Tabar-Comellas, G.
    Diezma-Martin, A.
    Quintana-Castro, P.
    Ennazeh, M.
    Lopez-Ariztegui, N.
    MOVEMENT DISORDERS, 2024, 39 : S392 - S392
  • [44] Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial
    Freire-Alvarez, Eric
    Kurca, Egon
    Lopez Manzanares, Lydia
    Pekkonen, Eero
    Spanaki, Cleanthe
    Vanni, Paola
    Liu, Yang
    Sanchez-Solino, Olga
    Barbato, Luigi M.
    MOVEMENT DISORDERS, 2021, 36 (11) : 2615 - 2623
  • [45] Comment on: “Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review”
    Andrew T. Lambarth
    CNS Drugs, 2016, 30 : 1007 - 1008
  • [46] Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"
    Lambarth, Andrew T.
    CNS DRUGS, 2016, 30 (10) : 1007 - 1008
  • [47] Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Maria Giovanna
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (11) : 1383 - 1384
  • [48] Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait
    Cossu, Giovanni
    Ricchi, Valeria
    Pilleri, Manuela
    Mancini, Francesca
    Murgia, Daniela
    Ricchieri, Gianluigi
    Mereu, Alessandra
    Melis, Maurizio
    Antonini, Angelo
    NEUROLOGICAL SCIENCES, 2015, 36 (09) : 1683 - 1686
  • [49] Direct Endoscopic Jejunostomy for the Administration of Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
    Vinh-an Phan
    Schoeman, Mark
    Kimber, Thomas
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB307 - AB308
  • [50] Study On Patient- And Caregiver-Reported Symptoms And Outcomes With Levodopa-Carbidopa Intestinal Gel For The Treatment Of Advanced Parkinson's Disease. ADEQUA Study
    Valldeoriola, F.
    Catalan, M. J.
    Escamilla-Sevilla, F.
    Freire, E.
    Olivares, J.
    Cubo, E.
    Santos, D.
    Parra, J. C.
    Arroyo, G.
    Arbelo, J. M.
    MOVEMENT DISORDERS, 2018, 33 : S120 - S120
12345